iOWH. (iOWH) is a non profit health institute. The institute is principally engaged in discovery and development of drugs to treat infectious diseases like diarrheal diseases, visceral leishmaniasis also known as kala-azar, soil-transmitted helminthiasis (STH), malaria, chagas disease. The product pipeline of the institute include paromomycin, synthetic artemisinin, and product 1. It is involved in treating millions of people in developing and poor countries. The institute has collaborated with many hospitals in the US and abroad to bridge the gap between development of new medicines, regulatory approval and manufacturing the drugs. iOWH is headquartered at San Francisco in California, the US.